Literature DB >> 30187336

Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram.

Yanwu Sun1, Yiyi Zhang1, Zhekun Huang1, Pan Chi2.   

Abstract

PURPOSE: This study aimed to investigate the prognostic significance of negative lymph nodes (NLNs) for ypN+ rectal cancer after neoadjuvant chemoradiotherapy (nCRT) and radical surgery and to construct a nomogram predicting disease-free survival (DFS).
METHOD: One hundred fifty-eight eligible patients were included. X-tile analysis was performed to determine cutoff values of NLNs. Clinicopathological and survival outcomes were compared. A Cox regression analysis was performed to identify prognostic factors of DFS. A nomogram was constructed and validated internally.
RESULTS: X-tile analysis identified cutoff values of 4 and 16 in terms of DFS (χ2 = 8.129, p = 0.017). The 3-year DFS rates for low (≤ 4), middle (5-16), and high (≥ 17) NLNs group was 15.2, 55.5, and 73.1%, respectively (P = 0.017). NLN count (NLNs ≥ 17, HR = 0.400, P = 0.022), IMA nodal metastasis (HR = 1.944, P = 0.025), tumor differentiation (poor/anaplastic, HR = 1.805, P = 0.021), and ypT4 stage (HR = 7.787, P = 0.047) were independent prognostic factors of DFS. A predicting nomogram incorporating the four significant predictors was developed with a C-index of 0.64.
CONCLUSION: NLN count was an independent prognostic factor of DFS in patients with ypN+ rectal cancer following nCRT. A nomogram incorporating NLN count, IMA nodal metastasis, tumor differentiation, and ypT stage could stratify rectal cancer patients with different DFS and might be helpful during clinical decision-making.

Entities:  

Keywords:  Chemoradiotherapy; Negative lymph nodes; Nomogram; Prognosis; Rectal cancer

Year:  2018        PMID: 30187336     DOI: 10.1007/s11605-018-3942-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  40 in total

1.  Low Lymph Node Retrieval After Preoperative Chemoradiation for Rectal Cancer is Associated with Improved Prognosis in Patients with a Good Tumor Response.

Authors:  Hun Jin Kim; Jeong Seon Jo; Soo Young Lee; Chang Hyun Kim; Young Jin Kim; Hyeong Rok Kim
Journal:  Ann Surg Oncol       Date:  2014-11-14       Impact factor: 5.344

Review 2.  Systematic review of microsatellite instability and colorectal cancer prognosis.

Authors:  S Popat; R Hubner; R S Houlston
Journal:  J Clin Oncol       Date:  2005-01-20       Impact factor: 44.544

3.  Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes.

Authors:  Jingyu Deng; Han Liang; Dianchang Wang; Dan Sun; Xuewei Ding; Yi Pan; Xiangyu Liu
Journal:  Ann Surg Oncol       Date:  2009-12-29       Impact factor: 5.344

4.  Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer.

Authors:  Paul M Johnson; Geoff A Porter; Rocco Ricciardi; Nancy N Baxter
Journal:  J Clin Oncol       Date:  2006-08-01       Impact factor: 44.544

5.  Histological and immunohistochemical study on sentinel lymph node in colorectal cancer - values and limitations.

Authors:  Stelian ŞtefăniŢă Mogoantă; Firmilian Calotă; Ion Vasile; Antoanela Valentina Crafciuc; Mircea Constantin Gherghinescu; Konstantinos Sapalidis; Daniel Sorin Ilie; Daniela Adriana Ion
Journal:  Rom J Morphol Embryol       Date:  2016       Impact factor: 1.033

6.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial.

Authors:  Willem van Gijn; Corrie A M Marijnen; Iris D Nagtegaal; Elma Meershoek-Klein Kranenbarg; Hein Putter; Theo Wiggers; Harm J T Rutten; Lars Påhlman; Bengt Glimelius; Cornelis J H van de Velde
Journal:  Lancet Oncol       Date:  2011-05-17       Impact factor: 41.316

7.  Number of negative lymph nodes is associated with survival in thoracic esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy.

Authors:  Zhengfei Zhu; Haiquan Chen; Weiwei Yu; Xiaolong Fu; Jiaqing Xiang; Hecheng Li; Yawei Zhang; Menghong Sun; Qiao Wei; Weixin Zhao; Kuaile Zhao
Journal:  Ann Surg Oncol       Date:  2014-04-18       Impact factor: 5.344

8.  The oncologic benefit of high ligation of the inferior mesenteric artery in the surgical treatment of rectal or sigmoid colon cancer.

Authors:  Chih-Chien Chin; Chien-Yuh Yeh; Reiping Tang; Chung-Rong Changchien; Wen-Shih Huang; Jeng-Yi Wang
Journal:  Int J Colorectal Dis       Date:  2008-04-26       Impact factor: 2.571

9.  Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction.

Authors:  Shuji Ogino; Katsuhiko Nosho; Natsumi Irahara; Kaori Shima; Yoshifumi Baba; Gregory J Kirkner; Mari Mino-Kenudson; Edward L Giovannucci; Jeffrey A Meyerhardt; Charles S Fuchs
Journal:  Am J Gastroenterol       Date:  2009-10-06       Impact factor: 10.864

10.  Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists.

Authors:  S George; J Primrose; R Talbot; J Smith; M Mullee; D Bailey; C du Boulay; H Jordan
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

View more
  5 in total

1.  Nomogram Predicting Overall Survival of Resected Locally Advanced Rectal Cancer Patients with Neoadjuvant Chemoradiotherapy.

Authors:  Jianyuan Song; Zhuhong Chen; Daxin Huang; Yimin Wu; Zhuangbin Lin; Pan Chi; Benhua Xu
Journal:  Cancer Manag Res       Date:  2020-08-18       Impact factor: 3.989

2.  BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy.

Authors:  Hengchang Liu; Ran Wei; Chunxiang Li; Zhixun Zhao; Xu Guan; Ming Yang; Zheng Liu; Xishan Wang; Zheng Jiang
Journal:  Cancer Manag Res       Date:  2020-10-20       Impact factor: 3.989

3.  Log odds of positive lymph nodes is an excellent prognostic factor for patients with rectal cancer after neoadjuvant chemoradiotherapy.

Authors:  Tianlei Xu; Lin Zhang; Liang Yu; Yuelu Zhu; Hui Fang; Bo Chen; Haizeng Zhang
Journal:  Ann Transl Med       Date:  2021-04

4.  Assessment of Systemic Inflammation and Nutritional Indicators in Predicting Recurrence-Free Survival After Surgical Resection of Gastrointestinal Stromal Tumors.

Authors:  Zhenhua Lu; Rui Li; Xianglong Cao; Chengyu Liu; Zhen Sun; Xiaolei Shi; Weiwei Shao; Yangyang Zheng; Jinghai Song
Journal:  Front Oncol       Date:  2021-07-26       Impact factor: 6.244

5.  Risk factors for long-term survival in patients with ypN+ M0 rectal cancer after radical anterior resection.

Authors:  Marcin Zeman; Władysław Skałba; Piotr Szymański; Grzegorz Hadasik; Dmytro Żaworonkow; Dominik A Walczak; Agnieszka Czarniecka
Journal:  BMC Gastroenterol       Date:  2022-03-26       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.